|
Volumn 5, Issue 11, 2004, Pages 645-
|
Progress in cancer fight for developing world
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRACYCLINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
METHOTREXATE;
ANTINEOPLASTIC AGENT;
BURKITT LYMPHOMA;
CANCER CONTROL;
CANCER INCIDENCE;
CANCER PALLIATIVE THERAPY;
CANCER SURVIVAL;
CHILDHOOD CANCER;
CLINICAL TRIAL;
DEVELOPING COUNTRY;
DRUG COST;
DRUG DOSE REDUCTION;
ENDEMIC DISEASE;
EPSTEIN BARR VIRUS;
HUMAN;
MALAWI;
NEPHROTOXICITY;
NOTE;
PRIORITY JOURNAL;
ARTICLE;
CHILD;
CHILD WELFARE;
ECONOMICS;
VIROLOGY;
VIRUS INFECTION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BURKITT LYMPHOMA;
CHILD;
CHILD WELFARE;
CLINICAL TRIALS;
DEVELOPING COUNTRIES;
DRUG COSTS;
EPSTEIN-BARR VIRUS INFECTIONS;
HUMANS;
MALAWI;
|
EID: 13944270376
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(04)01622-5 Document Type: Note |
Times cited : (1)
|
References (0)
|